Navigation Links
Medicinal Use of Marijuana: Past, Present and Future...A Fresh Look by Experts in the Field
Date:11/9/2009

WESTON, Mass., Nov. 9 /PRNewswire/ -- Groundbreaking articles in current issues of Journal of Opioid Management, for the first time explore, in depth, the emergence of cannabinoid medicine, its challenges for health care providers and its potential benefits for patients.

In these important articles, University of Washington authors, Sunil Aggarwal, PhD who is a member of the prestigious Medical Scientist Training Program and who conducted the article's research and Gregory T. Carter, MD, nationally recognized expert in the field of pain management, lead their team in taking a fresh look at all aspects of cannabinoid medicines, including the cannabinoid botanical marijuana, from the historical perspective and clinical evidence base for its use to the legal ramifications. In the second article, they offer a chart review examination of the treatment with medical cannabis of 139 chronic pain patients in the state of Washington.

As the authors point out, there is a near complete absence of education about cannabinoid medicine at any level of medical training despite the fact the Institute of Medicine concluded, after reviewing relevant scientific literature including dozens of works documenting marijuana's therapeutic value, that nausea, appetite loss, pain, and anxiety are all afflictions of wasting and all can be mitigated by the drug safely and with minimal toxicity. The research also shows that cannabinoid medicines have particular application for patients intolerant or refractory of opioid therapies for pain management.

The authors conclude that while cannabis is neither a miracle drug nor the answer to everyone's ills, the evidence suggests that physicians and medical students should make an extra effort to educate themselves in the art and science of cannabinoid medicine.

To purchase a reprint of Medicinal use of cannabis in the United States: Historical perspectives, current trends, and futur
'/>"/>

SOURCE Journal of Opioid Management
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP)
2. IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP)
3. IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival
4. Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting
5. Pharmacyclics to Present at Merriman Curhan Fords Investor Summit 2009
6. Clarient to Present at Upcoming Healthcare Investor Conferences in New York City
7. DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009
8. Watson to Present at Credit Suisse Healthcare Conference
9. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
10. Cantel Medical Corp. to Present at the Sidoti Emerging Growth Research Institutional Investor Forum
11. BD to Present at Investor Healthcare Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...J., Nov. 20 BD (Becton, ...ced the completion of its acquisition of HandyLab,...evelops and manufactures molecular diagnostic assa... and HandyLab announced an exclusive agreement for...on the HandyLab Jaguar(TM) platform, the first ful...
(Date:11/19/2009)...ov. 19 Warner Chilcott plc (Nasdaq...ously announced secondary offering of 20,000,000 o...$22.25 per share. The selling shareholders includ... Merchant Banking, J.P. Morgan Partners (advised b...certain other institutional investors and members ...
(Date:11/19/2009)... Nov. 19 In a series of ...ce, Heska Corporation (Nasdaq: HSKA ) ("Heska" or...new and improved website. The upgraded site is th... programming to align the site with the company,s ...Logo: http://www.newscom.com/cgi-bin/prnh/200006...
Breaking Medicine Technology:BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Palatin Technologies Inc Receives U S Patent Allowance for Heart Failure Drug Candidate 13342 1Palatin Technologies Inc Receives U S Patent Allowance for Heart Failure Drug Candidate 13342 2Palatin Technologies Inc Receives U S Patent Allowance for Heart Failure Drug Candidate 13342 3New Director of Lab Sales for Polymathic Analytical Labs 13340 1New Director of Lab Sales for Polymathic Analytical Labs 13340 2Go Healthys Marquis Product Cholesterade 28R 29 at Your Fingertips on Google 53590 1Go Healthys Marquis Product Cholesterade 28R 29 at Your Fingertips on Google 53590 2
...OD, Israel--(BUSINESS WIRE)--Jul 9, 2007 - TransPh...any focused on the development,and commercializati... transdermal drug delivery technology, announced t...als demonstrating the,safety and pharmacokinetic p...treatment of osteoporosis., A seven day, repeated ...
...Rivaroxaban, a New Oral, Once-Daily Direct Factor ...p Vein Thrombosis and Pulmonary,Embolism Compared ..., GENEVA, July 8, 2007 - Late-breaking Phase III c...rnational Society on Thrombosis,and Haemostasis (I...ban (Xarelto®) achieved superior efficacy in t...
Other Medicine Technology:TransPharma Medical Announces Positive Results of Phase I Clinical,Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis,Treatment 2TransPharma Medical Announces Positive Results of Phase I Clinical,Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis,Treatment 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 2Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 4Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 5
(Date:11/20/2009)...W, Calif., Nov. 20 Omnic...ystem solutions to acute healthcare facilities, an...t Annual Piper Jaffray Healthcare Conference at t...mnicell Speakers: Randall A. Lipps, founder, chai...dent & CFO ,, Date: Tuesday, December 1, ...
(Date:11/20/2009).... 20 Today, iconic denim brand D...the launch of a capsule gift giving collection off...y season. This collection is inspired by and desi... Thanks and Giving® Program, a holiday fund...sumers to "give thanks for the healthy kids in you...
(Date:11/20/2009)...Calif., Nov. 20 Heritage Provider ...chard Merkin, announce that as of November 6, 2009...ts affiliated entities, have been acquired by Lake... ,, "We first and foremost want to assure all o...e dedicated to maintaining the high level of care ...
(Date:11/20/2009)...Jackson Healthcare® is pleased to announce its...network, to deliver multispecialty physicians for ...d permanent physician placement. , ... -- Jackson Healthcare is pleased to announce its ...etwork, to deliver multispecialty physicians for l...
(Date:11/20/2009)...Nov. 20 Reportlinker.com announces... its catalogue. ,, Imaging Agents - A Worldwid...om/p0164325/Imaging-Agents---A-Worldwide-Market-Re...amp;utm_campaign=prnewswire ,, Development of...of organs within the human body. With their inhere...
Breaking Medicine News(10 mins):Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 3Health News:Heritage Provider Network CEO Dr. Richard Merkin, Announces the Acquisition of Lakeside Medical Systems, Inc. 2Health News:Heritage Provider Network CEO Dr. Richard Merkin, Announces the Acquisition of Lakeside Medical Systems, Inc. 3Health News:VHA Names Jackson Healthcare as Preferred Physician Staffing Vendor 2Health News:VHA Names Jackson Healthcare as Preferred Physician Staffing Vendor 3Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 2Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 3Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 4Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 5Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 6Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 7Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 8Health News:Reportlinker Adds Imaging Agents - A Worldwide Market Review 9
...althcare Veteran Joins Company,s Executive Team, ...ion (NYSE: AGP ) today announced that Mary McClus...versee healthcare services for the,Company,s 1.5 m...roughout her,career, she has distinguished herself...
... A preliminary study suggests that patients with c...r performance in some driving skills compared with...eport in the September issue of Archives of Otolar...erceptualmotor functions that work together. These...
...MPA, Fla., Sept. 17 The following public,service ...orida,s one million diabetics happens one person a...etic Counts Medicare Project is,looking for commit...er 26th.,Reserve your place in this free, two and ...
...W YORK, Sept. 17 Metropolitan Jewish Geriatric Ce... new position as Director,Social Work. Ms. Lerner ...y,with Metropolitan Jewish Health System to her ro...he Social,Work Department at MJGC. Ms. Lerner,s de...
...DWOOD CITY, Calif., Sept. 17 Genomic,Health, Inc...., Ph.D.,Genomic Health,s Chairman and Chief Execut...ers Fifth Annual Growth Conference in San Francisc...elations section of Genomic Health,s,website at h...
...inton Takes Over $1 Million From Insurers, Would F... MONICA, Calif., Sept. 17 The,Foundation for Taxp...nator,Hillary Clinton,s mandatory health insurance...hat would require every American to buy private,he...
Other Medicine News:Health News:AMERIGROUP Names Mary McCluskey, MD, Chief Medical Officer 2Health News:AMERIGROUP Names Mary McCluskey, MD, Chief Medical Officer 3Health News:Patients with head and neck cancer may have impairment of some driving skills 2Health News:Genomic Health to Present at ThinkEquity Partners Fifth Annual Growth Conference 2Health News:Consumer Group: Hillary Clinton's Mandatory Health Insurance Purchase Plan is an Act of War on the Middle Class Family That Can't Afford $12k Policy 2Health News:Consumer Group: Hillary Clinton's Mandatory Health Insurance Purchase Plan is an Act of War on the Middle Class Family That Can't Afford $12k Policy 3
Creatinine Test Kit (enzymatic)
Creatine Kinase Kinetic Reagent
Creatine Kinase Reagent
Creatinine
Medicine Products: